rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Paul Mintz

Director

Company insider

Files Form 4 as: Director, Cytomedix Inc Com New; Director, Immucor.

In numbers

Trades disclosed
24
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
2
First trade
7 Jun 2010
Last trade
29 Jun 2026
Last filed
2 Jul 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
Cytomedix Inc Com NewDirector · Medical Devices · last 29 Jun 20260 buys · 0 sells
ImmucorDirector · last 19 Aug 20110 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
29 Jun 2026filed 2 Jul 2026Cytomedix Inc Com Newoption or derivative · Medical DevicesSEC FORM 4 Code A—30,000 at $0.00filing
29 Jun 2026filed 2 Jul 2026Nuo Therapeuticsoption or derivativeSEC FORM 4 Code A—30,000 at $0.00filing
9 Dec 2025filed 11 Dec 2025Nuo TherapeuticsSEC FORM 4 Code M$20K50,000 at $0.40filing
9 Dec 2025filed 11 Dec 2025Nuo TherapeuticsSEC FORM 4 Code F$20K9,091 at $2.20filing
9 Dec 2025filed 11 Dec 2025Nuo TherapeuticsSEC FORM 4 Code M$20K50,000 at $0.40filing
9 Dec 2025filed 11 Dec 2025Nuo TherapeuticsSEC FORM 4 Code F$20K9,091 at $2.20filing
1 Aug 2025filed 4 Aug 2025Nuo TherapeuticsSEC FORM 4 Code M$35K87,500 at $0.40filing
1 Aug 2025filed 4 Aug 2025Nuo TherapeuticsSEC FORM 4 Code F$35K20,115 at $1.74filing
17 Jul 2024filed 22 Jul 2024Nuo Therapeuticsoption or derivativeSEC FORM 4 Code A$8,25025,000 at $0.33filing
4 Mar 2022filed 26 Apr 2022Nuo Therapeuticsoption or derivativeSEC FORM 4 Code A—26,666 at $0.00filing
4 Mar 2022filed 26 Apr 2022Nuo Therapeuticsoption or derivativeSEC FORM 4 Code A—75,000 at $0.00filing
31 Dec 2018filed 11 Dec 2025Nuo Therapeuticsoption or derivativeSEC FORM 4 Code M—50,000 at $0.00filing
31 Dec 2018filed 11 Dec 2025Nuo Therapeuticsoption or derivativeSEC FORM 4 Code M—50,000 at $0.00filing
31 Dec 2018filed 3 Jan 2019Nuo Therapeuticsoption or derivativeSEC FORM 4 Code A—50,000 at $0.00filing
9 Aug 2018filed 4 Aug 2025Nuo Therapeuticsoption or derivativeSEC FORM 4 Code M—87,500 at $0.00filing
9 Aug 2018filed 13 Aug 2018Nuo Therapeuticsoption or derivativeSEC FORM 4 Code A—87,500 at $0.00filing
10 May 2017filed 10 Jul 2017Nuo Therapeuticsoption or derivativeSEC FORM 4 Code A—18,750 at $0.00filing
19 Aug 2011filed 23 Aug 2011Immucoroption or derivativeSEC FORM 4 Code U—5,542 at $0.00filing
19 Aug 2011filed 23 Aug 2011Immucoroption or derivativeSEC FORM 4 Code U—19,500filing
19 Aug 2011filed 23 Aug 2011Immucoroption or derivativeSEC FORM 4 Code U—4,103filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Scott M. PittmanDirector and 10% owner · Director and 10% owner at Nuo Therapeutics, filing Form 4 there in the last year
David Emerson JordenCEO/CFO · CEO/CFO at Nuo Therapeutics, filing Form 4 there in the last year
C. Eric WinzerDirector · Director at Nuo Therapeutics, filing Form 4 there in the last year
Peter ClausenCso/COO · Cso/COO at Nuo Therapeutics, filing Form 4 there in the last year